State Street’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.34M | Buy |
741,052
+405,682
| +121% | +$4.56M | ﹤0.01% | 2694 |
|
|
2025
Q1 | $1.91M | Buy |
335,370
+96,541
| +40% | +$550K | ﹤0.01% | 3262 |
|
|
2024
Q4 | $2.35M | Buy |
238,829
+22,808
| +11% | +$224K | ﹤0.01% | 3266 |
|
|
2024
Q3 | $1.76M | Sell |
216,021
-36,296
| -14% | -$296K | ﹤0.01% | 3363 |
|
|
2024
Q2 | $3.37M | Sell |
252,317
-412,320
| -62% | -$5.51M | ﹤0.01% | 3091 |
|
|
2024
Q1 | $30.8M | Buy |
664,637
+13,296
| +2% | +$617K | ﹤0.01% | 1973 |
|
|
2023
Q4 | $44M | Buy |
651,341
+89,998
| +16% | +$6.08M | ﹤0.01% | 1774 |
|
|
2023
Q3 | $40.6M | Buy |
561,343
+44,249
| +9% | +$3.2M | ﹤0.01% | 1748 |
|
|
2023
Q2 | $38.5M | Buy |
517,094
+149,406
| +41% | +$11.1M | ﹤0.01% | 1827 |
|
|
2023
Q1 | $19.6M | Buy |
367,688
+20,025
| +6% | +$1.07M | ﹤0.01% | 2248 |
|
|
2022
Q4 | $23.5M | Buy |
347,663
+17,896
| +5% | +$1.21M | ﹤0.01% | 2124 |
|
|
2022
Q3 | $41.2M | Buy |
329,767
+19,471
| +6% | +$2.43M | ﹤0.01% | 1732 |
|
|
2022
Q2 | $29.5M | Buy |
310,296
+210,294
| +210% | +$20M | ﹤0.01% | 1970 |
|
|
2022
Q1 | $16.1M | Buy |
100,002
+5,060
| +5% | +$816K | ﹤0.01% | 2545 |
|
|
2021
Q4 | $31.6M | Buy |
+94,942
| New | +$31.6M | ﹤0.01% | 2137 |
|